NCT04522310View on ClinicalTrials.gov

ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis

CompletedOBSERVATIONAL
Enrollment

183

Participants

Timeline

Start Date

July 7, 2020

Primary Completion Date

February 28, 2021

Study Completion Date

May 29, 2021

Conditions
Covid19
Interventions
OTHER

MR-Pro-ADM

Dosage of MR-pro-ADM

Trial Locations (8)

59100

Hospital of Roubaix, Roubaix

59200

Hospital of Tourcoing, Tourcoing

59240

Hospital of Dunkerque, Dunkirk

59300

Hospitalier of Valenciennes, Valenciennes

59507

Hospital of DOUAI, Douai

62000

Hospital of Arras, Arras

62200

Hospital of Boulogne/mer, Boulogne-sur-Mer

62307

Hospital Dr Schaffner, Lens

All Listed Sponsors
lead

Centre Hospitalier de Lens

OTHER

NCT04522310 - ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis | Biotech Hunter | Biotech Hunter